Inosine triphosphate pyrophosphatase and thiopurine S-methyltransferase genotypes relationship to azathioprine-induced myelosuppression

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 1, 2006, Pages 44-49

  Zelinkova, Zuzana ^a   Derijks, Luc J J ^b   Stokkers, Pieter C F ^a   Vogels, Esther W M ^a   Van Kampen, Antoine H C ^a   Curvers, Wouter L ^a   Cohn, Danny ^a   Van Deventer, Sander J H ^a   Hommes, Daniël W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; INORGANIC PYROPHOSPHATASE; INOSINE TRIPHOSPHATE PYROPHOSPHATASE; MESALAZINE; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DOSE RESPONSE; ENTERITIS; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; THROMBOCYTOPENIA; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZATHIOPRINE; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPATITIS, TOXIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LEUKOPENIA; MALE; METHYLTRANSFERASES; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PYROPHOSPHATASES; RETROSPECTIVE STUDIES;

EID: 31144446293     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2005.10.019     Document Type: Article

References (18)

1. A.G. Fraser, T.R. Orchard, D.P. Jewell The efficacy of azathioprine for the treatment of inflammatory bowel disease a 30 year review Gut 50 2002 485 489
2. D.C. Pearson, G.R. May, G.H. Fick Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis Ann Intern Med 123 1995 132 142
3. W.J. Sandborn A review of immune modifier therapy for inflammatory bowel disease azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am J Gastroenterol 91 1996 423 433
4. D.J. de Jong, L.J. Derijks, A.H. Naber Safety of thiopurines in the treatment of inflammatory bowel disease Scand J Gastroenterol Suppl 239 2003 69 72
5. B.S. Kirschner Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease Gastroenterology 115 1998 813 821
6. D.H. Present, S.J. Meltzer, M.P. Krumholz 6-Mercaptopurine in the management of inflammatory bowel disease short- and long-term toxicity Ann Intern Med 111 1989 641 649
7. W.R. Connell, M.A. Kamm, J.K. Ritchie Bone marrow toxicity caused by azathioprine in inflammatory bowel disease 27 years of experience Gut 34 1993 1081 1085
8. M.C. Dubinsky, S. Lamothe, H.Y. Yang Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease Gastroenterology 118 2000 705 713
9. A. Ansari, C. Hassan, J. Duley Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease Aliment Pharmacol Ther 16 2002 1743 1750
10. A.J. Black, H.L. McLeod, H.A. Capell Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine Ann Intern Med 129 1998 716 718
11. L. Lennard TPMT in the treatment of Crohn's disease with azathioprine Gut 51 2002 143 146
12. S. Sumi, A.M. Marinaki, M. Arenas Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency Hum Genet 111 2002 360 367
13. A.M. Marinaki, A. Ansari, J.A. Duley Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase) Pharmacogenetics 14 2004 181 187
14. R.B. Gearry, R.L. Roberts, M.L. Barclay Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine Pharmacogenetics 14 2004 779 781
15. C.R. Yates, E.Y. Krynetski, T. Loennechen Molecular diagnosis of thiopurine S-methyltransferase deficiency genetic basis for azathioprine and mercaptopurine intolerance Ann Intern Med 126 1997 608 614
16. J.F. Colombel, N. Ferrari, H. Debuysere Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy Gastroenterology 118 2000 1025 1030
17. L.J. Derijks, L.P. Gilissen, L.G. Engels Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease implications for therapy Ther Drug Monit 26 2004 311 318
18. D. Allorge, R. Hamdan, F. Broly ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression Gut 54 2005 565